Poland· PL-100434994

Aviorexan

A other antiemetics product containing dimenhydrinatum + coffeinum, registered in Poland by Biofarm Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.

ATC A04AD

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAviorexanATCA04ADREGISTER NO.PL-100434994PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Dimenhydrinatum + coffeinum is registered in 5 of 19 countries.

Countries holding a registration under ATC A04AD (other antiemetics), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Dimenhydrinatum + coffeinum · ATC A04AD

5 / 19 countries

  • Canada
  • Czechiaprice
  • Ireland
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Dimenhydrinatum + Coffeinum
Manufacturer
Biofarm Sp. z o.o.
Country
Poland (PL)
ATC code
A04AD
ATC class
Other antiemetics
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991468590

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dimenhydrinatum + coffeinum in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dimenhydrinatum + coffeinum products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Austria · Neo Emedyl
  • Bulgaria · Нео Емедил
  • Spain · Cinfamar Cafeína, Normostop Cafeína
  • France · Mercalm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/34fae161-abb3-48e0-b46f-efa949debcd8
GET /v1/drugs/34fae161-abb3-48e0-b46f-efa949debcd8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "50 mg + 50 mg",
  "packaging": "05909991468590 ¦ OTC ¦ 141705\n10 tabl.",
  "substance": "Dimenhydrinatum 50 mg + Coffeinum 50 mg",
  "common_name": "Dimenhydrinatum + Coffeinum",
  "pl_product_id": "100434994",
  "pozwolenie_nr": "26702",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about dimenhydrinatum + coffeinum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.